These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23322571)

  • 1. Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system.
    Chhablani J; Nieto A; Hou H; Wu EC; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1268-79. PubMed ID: 23322571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
    Hou H; Nieto A; Ma F; Freeman WR; Sailor MJ; Cheng L
    J Control Release; 2014 Mar; 178():46-54. PubMed ID: 24424270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.
    Hartmann KI; Nieto A; Wu EC; Freeman WR; Kim JS; Chhablani J; Sailor MJ; Cheng L
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):493-500. PubMed ID: 23448595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sustained dual drug delivery system for proliferative vitreoretinopathy.
    Xiao Y; Choi KS; Warther D; Huffman K; Landeros S; Freeman WR; Sailor MJ; Cheng L
    Drug Deliv; 2020 Dec; 27(1):1461-1473. PubMed ID: 33100053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.
    Hou H; Wang C; Nan K; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):557-66. PubMed ID: 26882530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics.
    Hou H; Huffman K; Rios S; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2755-63. PubMed ID: 25829415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy.
    Warther D; Xiao Y; Li F; Wang Y; Huffman K; Freeman WR; Sailor M; Cheng L
    Drug Deliv; 2018 Nov; 25(1):1537-1545. PubMed ID: 29996687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.
    Wang C; Hou H; Nan K; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2014 Dec; 129():74-82. PubMed ID: 25446320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.
    Nieto A; Hou H; Moon SW; Sailor MJ; Freeman WR; Cheng L
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1070-80. PubMed ID: 25613937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
    Souza MC; Fialho SL; Souza PA; Fulgêncio GO; Da Silva GR; Silva-Cunha A
    Curr Eye Res; 2014 Jan; 39(1):99-102. PubMed ID: 24325382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle.
    Cheng L; Anglin E; Cunin F; Kim D; Sailor MJ; Falkenstein I; Tammewar A; Freeman WR
    Br J Ophthalmol; 2008 May; 92(5):705-11. PubMed ID: 18441177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles.
    Nieto A; Hou H; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2013 Nov; 116():161-8. PubMed ID: 24036388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sustained intravitreal drug delivery system with remote real time monitoring capability.
    Hou H; Nieto A; Belghith A; Nan K; Li Y; Freeman WR; Sailor MJ; Cheng L
    Acta Biomater; 2015 Sep; 24():309-21. PubMed ID: 26087110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
    Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained delivery of a HIF-1 antagonist for ocular neovascularization.
    Iwase T; Fu J; Yoshida T; Muramatsu D; Miki A; Hashida N; Lu L; Oveson B; Lima e Silva R; Seidel C; Yang M; Connelly S; Shen J; Han B; Wu M; Semenza GL; Hanes J; Campochiaro PA
    J Control Release; 2013 Dec; 172(3):625-33. PubMed ID: 24126220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
    Daull P; Paterson CA; Kuppermann BD; Garrigue JS
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized Porous Silicon Nanoparticles Covalent-Bonded with Levofloxacin in Hydrogel Polymer as a Drug Delivery System.
    Kim H; Sohn H
    J Nanosci Nanotechnol; 2020 Aug; 20(8):4619-4623. PubMed ID: 32126628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles.
    Wu EC; Andrew JS; Cheng L; Freeman WR; Pearson L; Sailor MJ
    Biomaterials; 2011 Mar; 32(7):1957-66. PubMed ID: 21122914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.